Overview
- 181 inspections across 136 sites are on record.
- 146 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-09-11.
At a glance
Inspections
181
Sites
136
Observations
146
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Pooja Ghatalia, MD | 11 Sep 2023 | Human Drugs | |
| Granules Pharmaceuticals Inc. | 3 Aug 2023 | Human Drugs | |
| Phoenixville Hospital, LLC IRB | 20 Jun 2023 | Human Drugs | |
| Suken A. Shah, MD | 1 Jun 2023 | Medical Devices & Rad Health | View 483 → |
| Galera Therapeutics, Inc. | 20 Apr 2023 | Human Drugs |
Sites inspected
Pooja Ghatalia, MDPhiladelphia, United States1 insp.
Granules Pharmaceuticals Inc.Chantilly, United States1 insp.
Phoenixville Hospital, LLC IRBPhoenixville, United States1 insp.
Suken A. Shah, MDWilmington, United States1 insp.
Galera Therapeutics, Inc.Malvern, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Cynthia White5 shared
Gabrielle J Swain4 shared
Sam Pepe3 shared
Rochelle L Cross3 shared
Stephanie C Mangigian3 shared
Thomas E Friel3 shared
Yiyue Zhang2 shared
Kara A Scheibner2 shared
Lisa B Orr2 shared
Kyle S Hobson2 shared
Full investigator report
Get the verbatim findings behind Joseph L Despins' 146 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site